Related Experiment Video
Updated: Sep 30, 2026

Isolation of Soil Microorganisms Using iChip Technology
Published on: January 10, 2025
Microbial genomics and novel antibiotic discovery: new technology to search for new drugs
Thomas J Dougherty1, John F Barrett, Michael J Pucci
1Department of Microbiology, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492, USA. thomas_j_dougherty@groton.pfizer.com
Abstract:
The process of prokaryotic drug discovery has been a model of success for over fifty years, yet the number of exploited bacterial targets is a mere fraction, less than 0.1% of the potential targets (based on total number of bacterial genes identified by gene sequence projects). To better understand the potential for drug intervention, multiple paradigms have been established in the pharmaceutical industry, all with some semblance of commonality and uniqueness to provide proprietary positioning, yet no company has been successful to date in taking a genomics approach to the finish line of having a genomics-based drug on the market. Within this overview, we provide a strategic overview of a sample process for the identification, validation and exploitation of novel antibacterial targets ascertained through a bioinformatics-based genomics drug discovery program.
Related Concept Videos
Modern Molecular Taxonomy
Antibiotic Selection
Pharmacogenomics: Identification of New Drug Targets
Microorganisms in Medicine and Therapeutics
Applications of Molecular Taxonomy
Genome Size and the Evolution of New Genes
